This website is intended for healthcare professionals only.
Take a look at a selection of our recent media coverage:
2nd March 2023
Changing coffee intake from low (< 3 cups/month) to moderate (1 – 7 cups/week) levels in patients with metabolic syndrome over a three year period, reduces total body fat levels and may help as part of a weight management strategy according to an analysis by US and Spanish researchers.
Coffee intake appears to be associated with a wide range of health benefits, so much so that coffee can be considered part of a healthful diet. Moreover, a 2019 meta-analysis concluded that caffeine intake might promote weight, body mass index and body fat reduction which is all the more important given how obesity is a global concern with a 2016 estimate that 1.9 billion adults were overweight and of whom, 650 million were obese. However, rather than total body fat, the distribution of that fat is often more relevant to health risks. For example, visceral adiposity is associated with incident cardiovascular disease and cancer after adjustment for clinical risk factors and generalised adiposity. Furthermore, in recent years, techniques such as dual-energy x-ray absorptiometry (DXA) have been developed and provide a more accurate means of determining regional adiposity and thus cardiometabolic risk assessment.
In the current study, researchers used data collected from the ongoing PREMED-PLUS trial to assess the association between changes in caffeinated and decaffeinated coffee intake with concurrent changes in DXA-derived adiposity measures. The researchers assessed coffee intake as either low (< 3 cups/month), moderate (1- 7 cups/week) or high (> 1 cup/day) and this data was collected, together with DXA measurements, at baseline, after 6 and 12 months and then after 3 years.
Changes in Coffee intake and adiposity
A total of 1,483 participants with a a mean age of 65.3 years (47.5% women) were included in the study.
After adjustment for potential confounders, those whose coffee consumption increased from low to moderate (1 – 7 cups/week) were found to have a significantly lower total body fat level (Δ z-score of -0.06, p = 0.006) compared to those who maintained a low intake. In addition, trunk fat (-0.07, p = 0.009) and visceral adiposity tissue (-0.07, p = 0.029) were also significantly lowered. In contrast, increasing coffee intake to a higher level (> 1 cup/day) or any change with decaffeinated intake was not associated with changes in DXA measures.
The authors concluded that a small increase in coffee intake appeared to result in a significant reduction in measures of adiposity and may form part of a weight management strategy.
Henn M et al. Increase from low to moderate, but not high, caffeinated coffee consumption is associated with favorable changes in body fat. Clin Nutr 2023
13th July 2022
A greater coffee intake has been found to be inversely associated with levels of ischaemic heart disease and mortality in 147 countries over the last 20 years according the findings of an ecological study by Japanese researchers.
Coffee is a complex mixture of more than a thousand different chemicals, many of which are reported to be biologically active and its health-promoting properties are attributed to this rich phytochemistry. In fact a 2017 review found health benefits from coffee intake including a reduced all-cause mortality, cardiovascular mortality as well as cardiovascular disease and a lower risk of several specific cancers, neurological, metabolic, and liver conditions. Nevertheless, previous studies on the association between coffee drinking and cardiovascular disease do not suggest a beneficial health effect and actually imply that coffee drinking is potentially harmful. For instance, in a 1963 study, it was reported that the development of clinical coronary heart disease was associated with coffee intake. Furthermore, another study from the 1970’s concluded that there was a small risk of death from coronary heart disease linked to drinking coffee. Finally, a study from the 1980’s supported an independent, dose-responsive association of coffee consumption with clinically evident coronary heart disease, consistent with up to a threefold elevation in risk among heavy coffee drinkers. Nevertheless, over the subsequent decades, the link between coffee drinking and cardiovascular disease has moved from no noticeable effect to a protective effect such that there was a significant and inverse relationship with cardiovascular disease.
But why has the relationship between coffee intake and ischaemic heart disease (IHD) incidence and mortality changed over the years? This was the question asked by the Japanese team who undertook a longitudinal, ecological study between 1990 and 2018. The team were able to use the Global Burden of Disease (GBD) Study to extract age-standardised IHD incidence and mortality and the Global Dietary Database to determine population level coffee intake data for a large number of different countries included in the Global burden of disease study from 1990 to 2018.
Coffee intake and ischaemic heart disease
Overall, the Japanese team used data from 147 countries, each with over a million inhabitants. Coffee intake, based on cups/day/population increased from a mean of 0.4 in 1990 to 0.8 in 2018 (p < 0.001). However, more interesting was that IHD incidence reduced over the same period of time from 338.7 cases/100,000 population in 1990 to 311.2 in 2018 (p = 0.073). In addition, a similar, but this time, statistically significant reduction occurred with IHD mortality (187.6/100,000 to 147.5, p < 0.001).
Using regression models adjusted for several lifestyle factors including smoking levels, physical activity and alcohol intake, it became clear that there was a significant inverse association between coffee intake and year as well as IHD incidence and mortality. In other words, the positive or harmful association between coffee intake and IHD mortality seen in the 1990’s changed to one of an inverse association and therefore protective effect over time.
In trying to understand why these changes had occurred, the authors speculated that the harmful affects of coffee in relation to IHD were probably related to confounders such as smoking, i.e., many people enjoy smoking a cigarette with their coffee and as smoking increased the risk of IHD, this may account for the observed positive association. Some support for this comes from a study which observed that smoking is known to modify the observed risk when studying the role of coffee on human health. Another possible reason for the change in observed health effects of coffee, might be due to shift from drinking boiled to filtered coffee. It was known that some ingredients in boiled coffee raised cholesterol levels and later work showed that the hyper-cholesterolaemic agent present in boiled coffee is retained by the paper filter.
They concluded that their study suggested how the association between coffee intake and IHD risk may change over time owing to changes in social and environmental factors.
Shirai Y et al. Change in the association between coffee intake and ischemic heart disease in an international ecological study from 1990 to 2018 Sci Rep 2022
11th April 2022
Coffee intake (whether ground or instant) of at least 2 – 3 cups per day has been found to be associated with significant reductions in the risk of developing cardiovascular disease (CVD), arrhythmias, as well as cardiovascular and all-cause mortality. This is according to the findings of three studies analysing data held within the UK Biobank.
Although coffee contains caffeine, it is also a rich source of phenolic compounds including chlorogenic acids which contribute to coffee’s antioxidant activity. Moreover, coffee intake at midlife has been associated with a lower risk of dementia and Alzheimer’s disease compared with those drinking no or only little coffee. However, the cardiovascular benefits from drinking coffee are less clear with one study finding that in men, the risk of nonfatal myocardial infarction was not associated with coffee drinking. In contrast, a large prospective study observed that coffee consumption was inversely associated with total and cause-specific mortality.
Due to these conflicting results, three studies presented at the American College of Cardiology Scientific Session have examined cardiovascular and mortality benefits disease associated with coffee intake.
In the first study, effects of habitual coffee consumption on incident cardiovascular disease, arrhythmia, and mortality: findings from UK BIOBANK, researchers from the University of Melbourne, Australia, included data from 382,535 individuals with a mean age of 57 years (52% female) and assessed the effect of coffee intake over a 10-year period. The results showed that a coffee intake of 2 – 3 cups/day was significantly associated (for all associations, p < 0.01) with the lowest risk for developing CVD (Hazard ratio, HR = 0.91, 95% CI 0.88 – 0.94), coronary heart disease (HR = 0.90), heart failure (HR = 0.85) and all-cause mortality (HR = 0.86). They found a U-shaped relationship between higher coffee intake and incident arrhythmia which was also lowest at 2 – 3 cups/day (HR = 0.92).
In the second study, regular coffee intake is associated with improved mortality in prevalent cardiovascular disease, the Australian team focused on the effect of coffee in patients with existing cardiovascular disease. With a population of 502,543 individuals, again followed for 10 years, CVD was subsequently diagnosed in 342,279 participants, of whom, 19.6% died. The team found that coffee intake was safe at all levels and that survival was improved again at 2 – 3 cups/day (HR = 0.92, 95% CI 0.86 – 0.99, p = 0.03). Among 24,111 participants diagnosed with an arrhythmia, drinking only one cup of coffee per day was associated with the lowest mortality risk (HR = 0.85) and specifically in those with atrial fibrillation or flutter, one cup of coffee per day was associated with improved survival (HR = 0.82, p < 0.01).
In the third study, ground, instant or decaffeinated coffee? Impact of different coffee subtypes on incident arrhythmia, cardiovascular disease and mortality, the team wondered if there were any differential cardiovascular benefits depending on how the coffee was prepared. Overall, they found that drinking between 1 and 5 cups of coffee per day were associated with a reduced risk of arrhythmia, CVD, CHD, heart failure and stroke. The greatest reduction in risk for CVD was seen with drinking 2 – 3 cups/day of ground coffee (HR = 0.83, 95% CI 0.79 – 0.87) but there was still a significant, albeit smaller, reduction in risk from consuming instant coffee (HR = 0.91, 95% CI 0.88 – 0.95).
Finally, in the third study, the authors showed that drinking 2 – 3 cups/day of decaffeinated coffee was associated with a mortality benefit (HR = 0.85, 95% CI 0.80 – 0.91, p < 0.01), leading the authors to conclude that non-caffeine compounds within coffee are likely to be important factors associated with greater survival among coffee drinkers.
Given these findings, the authors suggested that coffee intake should be considered as part of a healthy diet.